Toronto, Ontario--(Newsfile Corp. - September 14, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce its participation in the upcoming 3^rd Annual ArcStone-Kingswood Growth Summit in Toronto, taking place on September 16, 2026, at the Sheraton Center Toronto Hotel. Geoff Benic, Chief Executive Officer of Altrova Health, will be presenting on the company's recent milestones and future growth strategy.

The ArcStone-Kingswood Growth Summit will be hosting growth issuers and a curated group of investors, family offices, institutional investors, capital market professionals and service providers for a full day of company presentations, networking and 1-on-1 meetings.

Alongside the curated program of 1:1 meetings connecting investors with appropriate projects, the conference programme will provide keynote presentation, panel discussions and conversations on the industry developments.

Interested investors who would like to attend the ArcStone-Kingswood Growth Summit can register for a free pass here.

About ArcStone Securities and Investments Corp.

ArcStone Securities and Investments Corp. is a diversified financial services firm with offices in New York and Toronto. Our firm specializes in providing bespoke solutions to mid-market companies worldwide, with a particular focus on cross-border transactions between Canada and the United States. Our partnership with Kingswood US enhances our ability to offer a full spectrum of financial services to our clients.

About Kingswood US

Kingswood US is a mid-market investment bank with a strong retail equity capital markets franchise and deep rooted investment bank. The firm is dedicated to providing comprehensive financial services, including investment banking, wealth management, and capital raising, to clients across the United States.

About Altrova Health Inc.

Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness. The Company's current product portfolio includes exclusive Canadian distribution rights for the NIRLAB SA ("NIRLAB") NIRLIGHT drug analysis device, the O-Spray product line, and the rapid detection strip portfolio of its subsidiary Drug Lab 118 Ltd.

For more information, please visit: www.altrovahealth.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/314125

Source: ArcStone US Corp.